RBAK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.268400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.445800E-01
Normal-vs-Stage2
5.628100E-02
Normal-vs-Stage3
3.544400E-02
Normal-vs-Stage4
5.602200E-01
Stage1-vs-Stage2
2.804000E-01
Stage1-vs-Stage3
4.308400E-02
Stage1-vs-Stage4
9.329000E-01
Stage2-vs-Stage3
1.272840E-01
Stage2-vs-Stage4
3.200200E-01
Stage3-vs-Stage4
1.455200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.230200E-02
Normal-vs-AfricanAmerican
4.094600E-01
Normal-vs-Asian
1.314990E-01
Caucasian-vs-AfricanAmerican
2.814600E-01
Caucasian-vs-Asian
6.926600E-01
AfricanAmerican-vs-Asian
3.519800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.652100E-02
Normal-vs-Female
8.531500E-02
Male-vs-Female
2.950400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.516200E-01
Normal-vs-Age(41-60Yrs)
1.543600E-01
Normal-vs-Age(61-80Yrs)
3.951900E-02
Normal-vs-Age(81-100Yrs)
8.970100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.946000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.160000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.228800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.339140E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.112500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.171800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.355900E-03
Normal-vs-Daily Drinker
2.646500E-02
Normal-vs-Weekly Drinker
1.094430E-01
Normal-vs-Occasional Drinker
2.997000E-01
Normal-vs-Social Drinker
2.790800E-01
Non Drinker-vs-Daily Drinker
8.188400E-01
Non Drinker-vs-Weekly Drinker
2.856200E-01
Non Drinker-vs-Occasional Drinker
4.615700E-03
Non Drinker-vs-Social Drinker
1.019880E-02
Daily Drinker-vs-Weekly Drinker
4.434800E-01
Daily Drinker-vs-Occasional Drinker
2.042000E-02
Daily Drinker-vs-Social Drinker
3.654200E-02
Weekly Drinker-vs-Occasional Drinker
1.938180E-01
Weekly Drinker-vs-Social Drinker
2.555600E-01
Occasional Drinker-vs-Social Drinker
9.033000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.567400E-01
Normal-vs-Grade 2
4.651800E-02
Normal-vs-Grade 3
7.270000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.242000E-01
Grade 1-vs-Grade 3
8.117000E-01
Grade 1-vs-Grade 4
1.567400E-01
Grade 2-vs-Grade 3
2.126400E-01
Grade 2-vs-Grade 4
4.651800E-02
Grade 3-vs-Grade 4
7.270000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.039540E-02
Normal-vs-NonDiabetic
6.277600E-02
Diabetic-vs-NonDiabetic
6.176000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.371900E-02
Normal-vs-NoPancreatitis
4.672000E-02
Pancreatitis-vs-NoPancreatitis
8.824400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.565700E-02
Normal-vs-N1
6.566400E-02
N0-vs-N1
6.304000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.188600E-01
Normal-vs-TP53-NonMutant
3.152200E-01
TP53-Mutant-vs-TP53-NonMutant
6.718200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
